journal article·2000-01

Possibility of wound dressing using poly(l-leucine)/poly(ethylene glycol)/poly(l-leucine) triblock copolymer

Hyun-Jung Kim, Eun-Young Choi, Jong-Suk Oh, Hyun-Chul Lee, Sung-Sik Park, Chong-Su Cho

Biomaterials· Volume 21· Issue 2
Publisher page

Abstract

ABA-type block copolymers (abbreviated as LEL) composed of poly(L-leucine) (PLL) as the A component and poly(ethylene glycol) (PEG) as the B component were synthesized by ring-opening polymerization of L-leucine N-carboxyanhydride initiated by primary amino group located at both ends of PEG chain. A silver sulfadiazine (AgSD)-impregnated wound dressing of sponge type was prepared by the lyophilization method. Morphological structure of this wound dressing by scanning electron microscopy was observed to be composed of a dense skin layer and a porous inner layer. Equilibrium water content of LEL wound dressing increased with an increase in PEG content in the block copolymer due to the hydrophilicity of PEG. AgSD release from AgSD-impregnated wound dressing in PBS buffer (pH = 7.4) was dependent on PEG content in the block copolymer. Release of AgSD was increased in proportion to the PEG content in the copolymer. Antibacterial capacity of AgSD-impregnated wound dressing was examined in agar plate against Pseudomonas aeruginosa and Staphylococcus aureus. It was found that the suppression of bacterial proliferation in the wound dressing was dependent upon the PEG content. In cytotoxicity test, cell damage did not occur by the release of AgSD from the LEL sponge matrix of AgSD-medicated wound dressing. In in vivo test, granulous tissue formation and wound contraction for the AgSD- and dehydroepiandrosterone-impregnated LEL-2 wound dressing were faster than for any other groups.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Wound Healing and Treatments · Antimicrobial agents and applications · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
2. Silicone gel including antimicrobial agent10.1016/0007-1226(90)90048-5 ↗
3. A bilayer `artificial skin’ capable of sustained release of an antibiotic10.1016/0007-1226(91)90049-P ↗
4. Evaluation of a synthetic wound dressing capable of releasing silver sulfadiazine10.1097/00004630-199103000-00004 ↗
5. Design of an artificial skin. II. Control of chemical composition10.1002/jbm.820140203 ↗
6. Wound tissue can utilize a polymeric template to synthesize a functional extention of skin10.1126/science.7031899 ↗
7. Design of an artificial skin. I. Basic design principles10.1002/jbm.820140108 ↗
8. Development and use of a living skin equivalent10.1111/1523-1747.ep12539993 ↗
9. The reconstitution of living skin
10. Delayed wound gealing with adhesive wound dressings10.1111/j.1524-4725.1984.tb01276.x ↗
11. Development of sponge-like artificial skin from gelatin
12. Clinical evaluation of a new bilayer `artificial skin’ composed of collagen sponge and silicon layer10.1016/0007-1226(90)90044-Z ↗
13. Development of a new wound dressing with antimicrobial delivery capability10.1046/j.1524-475X.1994.20206.x ↗
14. Study of a silver-sulfadiazine-impregnated wound dressing composed of poly(l-leucine)
15. A silver-sulfadiazine-impregnated wound dressing composed of poly-l-leucine sponge matrix10.1002/jab.770030211 ↗
16. Primary excision and prompt grafting as routine therapy for the treatment of thermal burns in children10.1016/S0039-6109(16)40890-X ↗
17. Silver sulfadiazine—a new topocal therapy for pseudomonas in burns10.1001/archsurg.1968.01330200022004 ↗
18. The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo10.1111/j.1749-6632.1994.tb44246.x ↗
19. Dexamethasone up-regulates granulocyte-macrophage colony-stimulating factor receptor expression on human monocytes
20. Reversal of the immunosenescent phenotype by dehydroepiandrosterone10.1097/00000441-199307000-00004 ↗
21. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cell10.1016/S0090-1229(05)80024-8 ↗
22. Prednisolone release from copolyurethane monolithic devices10.1016/0168-3659(88)90052-1 ↗
23. Novel design of microreservoir-dispersed matrices for the drug delivery formulations10.1016/0168-3659(87)90086-1 ↗
24. Cho · 1993 · vol. 520 · 274
25. The mechanisms of polymerization of N-unsubstituted N-carboxyanhydride10.1021/ja00967a028 ↗
26. Synthesis structural study of an ABA block copolymer consisting of poly (γ-benzyl l-glutamate) as the A block and poly(ethylene oxide) as the B block10.1002/macp.1990.021910423 ↗
27. Synthesis and structural study of an ABA block copolymer consisting of poly(ε-benzyloxycarbonyl-l-lysine) as the A block and poly(ethylene oxide) as the B block10.1002/macp.1994.021950626 ↗
28. Evalution of biosynthetic bilaminar wound dressings containing an antibacterial drug
29. In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films10.1016/S0142-9612(98)00049-0 ↗
30. A new composite skin prosthesis10.1016/0305-4179(80)90038-8 ↗
31. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury10.1097/00000658-198110000-00005 ↗
32. Artificial dermis for major burns10.1097/00000658-198809000-00008 ↗
33. Polyethylene oxide as a biomaterial
34. Influence of glycosamnoglycans on the collagen sponge component of a bilayer artificial skin10.1016/0142-9612(90)90113-5 ↗
35. A bilayer artificial skin capable of sustained release of an antibiotic10.1016/0007-1226(91)90049-P ↗
36. Evalution of a bilayer artificial skin capable of sustained release of an antibiotic10.1016/0142-9612(92)90007-B ↗
37. Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroids10.1073/pnas.46.4.447 ↗
38. Adrenal androgen secretion and biologic effects10.1016/S0889-8529(18)30274-3 ↗
39. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells10.1002/eji.1830200413 ↗
40. Dehydroepiandrosterone reduces progressive dermal ischemia caused by thermal injury10.1006/jsre.1995.1162 ↗